Session IV: September 27, 2023
Prostate Cancer Survivor Stories and New Approved Therapies
Prostate cancer survivor stories offer vital learning experiences and inspiration for other patients. This session featured personal narratives from survivors with lessons that can benefit others navigating similar prostate cancer journeys. This session also included presentations showcasing recently FDA-approved prostate cancer diagnostics and therapeutics that are now available for patients.
Session IV Program
Watch Video Welcome and Opening Remarks: Mr. Thomas Farrington, President and Founder, PHEN
Watch Video Moderator: Mr. Barney Morris, PHEN Ambassador, Tampa, FL
Watch Video Prostate Cancer Survivor Stories
-
- Mr. Charles “Chuck” Christian, PHEN Survivor Network Member, Randolph, MA
- Mr. Llewellyn “Llew” Fambles, PHEN Survivor Network Member, Oklahoma City, OK
- Mr. Jerry Knight, PHEN Ambassador, Jackson, MS
- Mr. Lee Moultrie, PHEN Ambassador, North Charleston, SC
- Mr. William Thompson, PHEN Survivor Network Member, Los Angeles, CA
Watch Video Moderator: Keith Crawford, MD, PhD, Director of Clinical Trials and Patient Education, PHEN
Watch Video Newly FDA-Approved Prostate Cancer Diagnostics and Therapeutics
-
- Sumitomo Pharma: Jill Daigneault, PhD, Medical Science Liaison
- Blue Earth Diagnostics: Phillip Davis, MD, Nuclear Medicine Physician, Vice President, Clinical Development & Medical Affairs Advisor
- Bayer: Jay Jhaveri, MD, MPH, Director, Medical Affairs
- Lantheus: Daneil Kuftinec, MD, Medical Director of Global Medical Affairs
- Janssen Oncology: Jennifer Phillips, PhD, Group Medical Director
Watch Video Impact of Diet and Exercise on Prostate Cancer Progression in Men:
-
-
- June Chan, ScD, Professor & Vice Chair for Education, University of California, San Francisco
- Stacey A. Kenfield, ScD, Professor, Associate Chair of Research, Urology at University of California, San Francisco
-
Watch Video Heroes in Memoriam: Mr. Thomas Farrington
Watch Video Closing Remarks: Mr. Thomas Farrington
